XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Accounts Receivable

The following is a summary of the Company’s accounts receivable at September 30, 2024 and December 31, 2023:

  

   September 30, 2024   December 31, 2023 
         
Accounts receivable  $1,636,306   $1,274,112 
Less: allowance for doubtful accounts   81,772    81,772 
Accounts receivable - net  $1,554,534   $1,192,340 
Schedule of Concentration of Risk

The Company has the following concentrations related to its sales, accounts receivable and vendor purchases greater than 10% of their respective totals:

  

Sales

 

   Nine Months Ended September 30, 
Customer  2024   2023 
A   20.41%   21.83%
B   10.46%   12.27%
Total   30.87%   34.10%

 

Accounts Receivable

 

   Nine Months Ended September 30,   Year Ended December 31, 2023 
Customer  2024   2023 
A   39.09%   46.57%
B   14.62%   13.50%
Total   53.71%   60.07%

 

Vendor Purchases

 

   Nine Months Ended September 30, 
Vendor  2024   2023 
A   42.86%   50.30%
B   43.39%   37.21%
C   13.62%   11.65%
Total   99.87%   99.16%
Schedule of Disaggregation of Revenue

The following represents the Company’s disaggregation of revenues for the nine months ended September 30, 2024 and 2023:

  

   Nine Months Ended September 30, 
   2024   2023 
    Revenue     % of Revenues    Revenue     % of Revenues 
                     
Fuel sales  $20,249,067    96.53%  $17,129,808    97.74%
Other   728,793    3.47%   395,869    2.26%
Total Sales  $20,977,860    100.00%  $17,525,677    100.00%
Schedule of Dilutive Equity Securities Outstanding

The following potentially dilutive equity securities outstanding as of September 30, 2024 and 2023 were as follows:

 

   September 30, 2024   September 30, 2023 
Series A, preferred stock   1,644,022    - 
Series B, preferred stock    724,638     - 
Series A, preferred stock - dividends   164,402    - 
Series B, preferred stock - dividends   72,464    - 
Warrants (vested)   52,297    81,452 
Total common stock equivalents    2,657,822     81,452